Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Migraine Prevention in Adolescents
NCT02344316Phase 2Completed
- Start
- May 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine comparing Melatonin with Placebo (2 arms). Primary endpoint: Number of Migraine/Migrainous Days Per 28 Day Period at 4 weeks. Started May 2015; status: completed.
02
Drugs
melatonin
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02344316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02344316.